The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptome Sequencing Based on RNA-seq Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 High-throughput
1.2.3 Low-throughput
1.3 Market by Application
1.3.1 Global Transcriptome Sequencing Based on RNA-seq Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology
1.3.3 Academic Research and Government Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptome Sequencing Based on RNA-seq Market Perspective (2018-2029)
2.2 Transcriptome Sequencing Based on RNA-seq Growth Trends by Region
2.2.1 Global Transcriptome Sequencing Based on RNA-seq Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Transcriptome Sequencing Based on RNA-seq Historic Market Size by Region (2018-2023)
2.2.3 Transcriptome Sequencing Based on RNA-seq Forecasted Market Size by Region (2024-2029)
2.3 Transcriptome Sequencing Based on RNA-seq Market Dynamics
2.3.1 Transcriptome Sequencing Based on RNA-seq Industry Trends
2.3.2 Transcriptome Sequencing Based on RNA-seq Market Drivers
2.3.3 Transcriptome Sequencing Based on RNA-seq Market Challenges
2.3.4 Transcriptome Sequencing Based on RNA-seq Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcriptome Sequencing Based on RNA-seq Players by Revenue
3.1.1 Global Top Transcriptome Sequencing Based on RNA-seq Players by Revenue (2018-2023)
3.1.2 Global Transcriptome Sequencing Based on RNA-seq Revenue Market Share by Players (2018-2023)
3.2 Global Transcriptome Sequencing Based on RNA-seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcriptome Sequencing Based on RNA-seq Revenue
3.4 Global Transcriptome Sequencing Based on RNA-seq Market Concentration Ratio
3.4.1 Global Transcriptome Sequencing Based on RNA-seq Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptome Sequencing Based on RNA-seq Revenue in 2022
3.5 Transcriptome Sequencing Based on RNA-seq Key Players Head office and Area Served
3.6 Key Players Transcriptome Sequencing Based on RNA-seq Product Solution and Service
3.7 Date of Enter into Transcriptome Sequencing Based on RNA-seq Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptome Sequencing Based on RNA-seq Breakdown Data by Type
4.1 Global Transcriptome Sequencing Based on RNA-seq Historic Market Size by Type (2018-2023)
4.2 Global Transcriptome Sequencing Based on RNA-seq Forecasted Market Size by Type (2024-2029)
5 Transcriptome Sequencing Based on RNA-seq Breakdown Data by Application
5.1 Global Transcriptome Sequencing Based on RNA-seq Historic Market Size by Application (2018-2023)
5.2 Global Transcriptome Sequencing Based on RNA-seq Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
6.2 North America Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
6.4 North America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
7.2 Europe Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
7.4 Europe Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
8.2 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Size by Region (2018-2023)
8.4 Asia-Pacific Transcriptome Sequencing Based on RNA-seq Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
9.2 Latin America Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
9.4 Latin America Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Size (2018-2029)
10.2 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Size by Country (2018-2023)
10.4 Middle East & Africa Transcriptome Sequencing Based on RNA-seq Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Transcriptome Sequencing Based on RNA-seq Introduction
11.1.4 Thermo Fisher Scientific Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Transcriptome Sequencing Based on RNA-seq Introduction
11.2.4 Illumina Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.2.5 Illumina Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Detail
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Transcriptome Sequencing Based on RNA-seq Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptome Sequencing Based on RNA-seq Introduction
11.4.4 Agilent Technologies Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.4.5 Agilent Technologies Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Transcriptome Sequencing Based on RNA-seq Introduction
11.5.4 Roche Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.5.5 Roche Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Detail
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Transcriptome Sequencing Based on RNA-seq Introduction
11.6.4 GE Healthcare Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.6.5 GE Healthcare Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Detail
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Transcriptome Sequencing Based on RNA-seq Introduction
11.7.4 Bio-Rad Laboratories Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Fluidigm
11.8.1 Fluidigm Company Detail
11.8.2 Fluidigm Business Overview
11.8.3 Fluidigm Transcriptome Sequencing Based on RNA-seq Introduction
11.8.4 Fluidigm Revenue in Transcriptome Sequencing Based on RNA-seq Business (2018-2023)
11.8.5 Fluidigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details